본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
Radiation hardness of cadmium telluride solar cells in proton therapy beam mode
()

Ahn Sang Hee
(Center for Proton Therapy)
. Radiation hardness of cadmium telluride solar cells in proton therapy beam mode. PLOS ONE. 2019-09-12; 2019; Online:Published. IF 2.776 (2018)
Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer
()


()
. Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer. JOURNAL OF CLINICAL ONCOLOGY. 2019-09-12; 2019; Online:Published. IF 28.349 (2018)
The association of integration patterns of human papilloma virus and single nucleotide polymorphisms on immune- or DNA repair-related genes in cervical cancer patients Joo-Young Kim
(Division of Convergence Technology)

Joo Jung nam
(Division of Cancer Epidemiology and Management)
. The association of integration patterns of human papilloma virus and single nucleotide polymorphisms on immune- or DNA repair-related genes in cervical cancer patients. SCIENTIFIC REPORTS. 2019-09-11; 2019; 9(1):13132~13132. IF 4.011 (2018)
Histologic Response and Toxicity following Interval-Compressed Four-Drug Therapy Given Preoperatively in Children and Young Adults with Osteosarcoma: A Retrospective Study Park Byung Kiu
(Division of Clinical Research)

Kang Ji Man
(Center for Pediatric Oncology)
. Histologic Response and Toxicity following Interval-Compressed Four-Drug Therapy Given Preoperatively in Children and Young Adults with Osteosarcoma: A Retrospective Study. ONCOLOGY. 2019-09-11; 2019; Online:Published. IF 2.278 (2018)
Oncolytic Ad co-expressing decorin and Wnt decoy receptor overcomes chemoresistance of desmoplastic tumor through degradation of ECM and inhibition of EMT
()

LIYAN
(Division of Translational Science)
. Oncolytic Ad co-expressing decorin and Wnt decoy receptor overcomes chemoresistance of desmoplastic tumor through degradation of ECM and inhibition of EMT. CANCER LETTERS. 2019-09-10; 2019; 459:15~29. IF 6.508 (2018)
Comprehensive Learning Curve of Robotic Surgery Discovery From a Multicenter Prospective Trial of Robotic Gastrectomy
()


()
. Comprehensive Learning Curve of Robotic Surgery Discovery From a Multicenter Prospective Trial of Robotic Gastrectomy. ANNALS OF SURGERY. 2019-09-09; 2019; Online:Published. IF 9.476 (2018)
A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046),
TRU-D
()


()
. A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D. JOURNAL OF GYNECOLOGIC ONCOLOGY. 2019-09-03; 2019; Online:Published. IF 2.914 (2018)
Comparison of Models for Tumor Recurrence after Liver Transplantation for the Patients with Hepatocellular Carcinoma: A Multicenter Long-Term Follow-Up Study
()

Cho Yu Ri
(Division of Clinical Research)
. Comparison of Models for Tumor Recurrence after Liver Transplantation for the Patients with Hepatocellular Carcinoma: A Multicenter Long-Term Follow-Up Study. CANCERS. 2019-09-03; 2019; 11(9):1295~1295. IF 6.162 (2018)
Changes of End of life Practices for Cancer Patients and Their Association with Hospice Palliative Care Referral over 2009-2014: A Single Institution Study
()

Jho, Hyun Jung
(National Hospice Center)
. Changes of End of life Practices for Cancer Patients and Their Association with Hospice Palliative Care Referral over 2009-2014: A Single Institution Study. CANCER RESEARCH AND TREATMENT. 2019-09-03; 2019; Online:Published. IF 3.363 (2018)
FAK-Copy-Gain Is a Predictive Marker for Sensitivity to FAK Inhibition in Breast Cancer Hong Kyeong Man
(Division of Cancer Branch)

Kim, Young Ho
(Division of Clinical Research)
. FAK-Copy-Gain Is a Predictive Marker for Sensitivity to FAK Inhibition in Breast Cancer. CANCERS. 2019-09-02; 2019; 11(9):e1288~e1288. IF 6.162 (2018)